Suppr超能文献

家庭透析使用和肾移植的按效付费激励措施。

Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant.

机构信息

Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.

Regenstrief Institute, Indianapolis, Indiana.

出版信息

JAMA Health Forum. 2024 Jun 30;5(6.9):e242055. doi: 10.1001/jamahealthforum.2024.2055.

Abstract

IMPORTANCE

The Centers for Medicare & Medicaid Services' mandatory End-Stage Renal Disease Treatment Choices (ETC) model, launched on January 1, 2021, randomly assigned approximately 30% of US dialysis facilities and managing clinicians to financial incentives to increase the use of home dialysis and kidney transplant.

OBJECTIVE

To assess the ETC's association with use of home dialysis and kidney transplant during the model's first 2 years and examine changes in these outcomes by race, ethnicity, and socioeconomic status.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used claims and enrollment data for traditional Medicare beneficiaries with kidney failure from 2017 to 2022 linked to same-period transplant data from the United Network for Organ Sharing. The study data span 4 years (2017-2020) before the implementation of the ETC model on January 1, 2021, and 2 years (2021-2022) following the model's implementation.

EXPOSURE

Receiving dialysis treatment in a region randomly assigned to the ETC model.

MAIN OUTCOMES AND MEASURES

Primary outcomes were use of home dialysis and kidney transplant. A difference-in-differences (DiD) approach was used to estimate changes in outcomes among patients treated in regions randomly selected for ETC participation compared with concurrent changes among patients treated in control regions.

RESULTS

The study population included 724 406 persons with kidney failure (mean [IQR] age, 62.2 [53-72] years; 42.5% female). The proportion of patients receiving home dialysis increased from 12.1% to 14.3% in ETC regions and from 12.9% to 15.1% in control regions, yielding an adjusted DiD estimate of -0.2 percentage points (pp; 95% CI, -0.7 to 0.3 pp). Similar analysis for transplant yielded an adjusted DiD estimate of 0.02 pp (95% CI, -0.01 to 0.04 pp). When further stratified by sociodemographic measures, including age, sex, race and ethnicity, dual Medicare and Medicaid enrollment, and poverty quartile, there was not a statistically significant difference in home dialysis use across joint strata of characteristics and ETC participation.

CONCLUSIONS AND RELEVANCE

In this cross-sectional study, the first 2 years of the ETC model were not associated with increased use of home dialysis or kidney transplant, nor changes in racial, ethnic, and socioeconomic disparities in these outcomes.

摘要

重要性

2021 年 1 月 1 日启动的医疗保险和医疗补助服务中心(CMS)强制性终末期肾脏疾病治疗选择(ETC)模式,将大约 30%的美国透析机构和管理临床医生随机分配到经济激励措施中,以增加家庭透析和肾脏移植的使用。

目的

评估 ETC 在该模型的头 2 年期间与家庭透析和肾脏移植的使用之间的关联,并检查按种族、族裔和社会经济地位划分的这些结果的变化。

设计、设置和参与者:这项回顾性的横断面研究使用了来自 2017 年至 2022 年的传统医疗保险受益人与肾衰竭相关的索赔和登记数据,并与美国器官共享网络同期的移植数据相链接。研究数据跨越了 4 年(2017-2020 年),在此之前,ETC 模型于 2021 年 1 月 1 日实施,在此之后的 2 年(2021-2022 年)。

暴露情况

在随机分配给 ETC 模型的地区接受透析治疗。

主要结果和措施

主要结果是家庭透析和肾脏移植的使用。采用差异-差异(DiD)方法来估计在随机选择参加 ETC 的地区接受治疗的患者的结果变化,与在对照地区接受治疗的患者的同期变化进行比较。

结果

研究人群包括 724406 名肾衰竭患者(平均[IQR]年龄,62.2[53-72]岁;42.5%为女性)。ETC 地区接受家庭透析的比例从 12.1%增加到 14.3%,对照地区从 12.9%增加到 15.1%,调整后的 DiD 估计值为-0.2 个百分点(95%CI,-0.7 至 0.3 个百分点)。对于移植的类似分析得出的调整后的 DiD 估计值为 0.02 个百分点(95%CI,-0.01 至 0.04 个百分点)。当按社会人口学措施进一步分层,包括年龄、性别、种族和民族、双重医疗保险和医疗补助登记以及贫困四分位数时,ETC 参与和家庭透析使用的联合特征之间没有统计学上显著的差异。

结论和相关性

在这项横断面研究中,ETC 模式的头 2 年与家庭透析或肾脏移植的使用增加无关,也与这些结果的种族、民族和社会经济差异没有变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53af/11215557/a8c84218d224/jamahealthforum-e242055-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验